India's First Dengue Vaccine Trial Near Completion, ICMR Reports

The Indian Council of Medical Research has stated that enrollment for the third phase of clinical trials for the country's first dengue vaccine is almost complete. This development marks a significant step in the fight against dengue, a disease that remains a major public health challenge. No antiviral treatment or licensed vaccine is currently available in India for dengue. The nation is among the top 30 countries with the highest dengue incidence. The trial aims to evaluate the safety and efficacy of the vaccine. Results from this phase will be crucial for potential approval and distribution. The initiative highlights ongoing efforts to address the growing burden of the disease. Public health officials are closely monitoring the progress of the trials.

This development could lead to a critical tool in combating a widespread and serious health issue in India.